Abstract
Competitive binding experiments first demonstrated that insulin-like growth factor (IGF) receptors are distinct from insulin receptors and that there are two IGF receptors based on relative preference for IGF-I, IGF-II, and insulin1. The IGF-I receptor or type I IGF receptor binds IGF-I with higher affinity than IGF-II, and binds insulin with much lower affinity than IGF-II. The IGF-II receptor or type II IGF receptor binds IGF-II with considerably higher affinity than IGF-I and does not bind insulin at all. The structures of these two IGF receptors were defined by affinity crosslinking, biosynthetic labeling, purification, and finally, molecular cloning2–5. The IGF-I receptor is very similar to the insulin receptor, consisting of two alpha subunits of 130 kDa, and two beta subunits of 95 kDa. The beta subunit has intrinsic tyrosine kinase activity which is activated by autophosphorylation following ligand binding to the alpha subunit. The structure of the IGF-II receptor is quite different from the structure of the IGF-I receptor. The IGF-II receptor is a single 250 kDa glycoprotein which lacks tyrosine kinase activity.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
M. M. Rechter and S. P. Nissley, The nature and regulation of the receptors for insulinlike growth factors, Ann. Rev. Physiol. 47:425 (1985).
A. Ullrich, A. Gray, A.W. Tarn, T. Yang-Feng, M. Tsubokawa, C. Collins, W. Henzel, T. Le Bon, S. Kathuria, E. Chen, S. Jacobs, U. Frank, J. Ramachandran, and Y. Fujita-Yamaguchi, Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity, EMBO J. 5:2503 (1986).
D. O. Morgan, J. C. Edman, D. N. Standring, V. A. Fried, M. C. Smith, R. A. Roth, and W. J. Rutter, Insulin-like growth factor II receptor as a multifunctional binding protein, Nature 329:301 (1987).
P. Lobel, N. M. Dahms, and S. Kornfeld, Cloning and sequence analysis of the cation-independent mannose 6-phosphate receptor, J. Biol. Chem. 263: 2563 (1988).
A. Oshima, C. M. Nolan, J. W. Kyle, J. H. Grubb, and W. S. Sly, The human cation-independent mannose 6-phosphate receptor. Cloning and sequence of the full-length cDNA and expression of functional receptor in cos cells, J. Biol. Chem. 263: 2553 (1988).
R. G. MacDonald, S. R. Pfeffer, L. Coussens, M. A. Tepper, C. M. Brocklebank, J. E. Mole, J. K. Anderson, E. Chen, M. P. Czech, and A. Ullrich, A single receptor binds both insulin-like growth factor II and mannose 6-phosphate, Science 239:1134 (1988).
R. A. Roth, C. Stover, J. Hari, D. O. Morgan, M. C. Smith, V. Sara, and V. A. Fried, Interactions of the receptor for insulin-like growth factor II with mannose-6-phosphate and antibodies to the mannose-6-phosphate receptor, Biochem. Biophys. Res. Commun. 149: 600 (1987).
W. Kiess, G. D. Blickenstaff, M. M. Sklar, C. L. Thomas, S. P. Nissley, and G. G. Sahagian, Biochemical evidence that the type II insulin-like growth factor receptor is identical to the cation-independent mannose 6-phosphate receptor, J. Biol. Chem. 263:9399 (1988).
P. Y. Tong, S. E. Tollefsen, and S. Kornfeld, The cation-independent mannose 6-phosphate receptor binds insulin-like growth factor II, J. Biol. Chem. 263: 2585 (1988)
T. Braulke, C. Causin, A. Waheed, U. Junghans, A. Hasilik, P. Maly, R. E. Humbel, and K. von Figura, Mannose 6-phosphate/insulin-like growth factor II receptor: distinct binding sites for mannose 6-phosphate and insuin-like growth factor II, Biochem. Biophys. Res. Commun. 150: 1287 (1988).
S. P. Nissley, W. Kiess, C. Thomas, M. Sklar, and G. G. Sahagian, Lysosomal enzymes inhibit binding of insulin-like growth factor II (IGF-II) to the IGF-II/Mannose-6-phosphate receptor, J. Cell Biol. 107: 704a (1989).
G. D. Blickenstaff, G. Terres, and G. G. Sahagian, Insulin-like growth factor II (IGF-II) and lysosomal enzymes bind to distinct but interacting sites on the mannose 6-phosphate (Man-6-P)/IGF-II receptor, J. Cell Biol. 107:62a (1989).
A. Waheed, T. Braulke, U. Junghans, and K. von Figura, Mannose 6-phosphate/insulin like growth factor II receptor: the two types of ligands bind simultaneously to one receptor at different sites, Biochem. Biophys. Res. Commun. 152:1248 (1988).
K. von Figura and A. Hasilik, Lysosomal enzymes and their receptors, Ann. Rev. Biochem. 55:167(1986)
S. Kornfeld, Trafficking of lysosomal enzymes, FASEB J. 1:462 (1987)
S. R. Pfeffer, Mannose 6-phosphate receptors and their role in targeting proteins to lysosomes, J. Membrane Biol. 103:7 (1988).
G. Griffiths, B. Hoflack, K. Simons, I. Mellman, and S. Kornfeld, The mannose 6-phosphate receptor and the biogenesis of lysosomes, Cell 52:329 (1988).
N. M. Dahms, P. Lobel, J. Breitmeyer, J.M. Chirgwin, and S. Kornfeld, 46 kd mannose 6-phosphate receptor: cloning, expression, and homology to the 215 kd mannose 6-phosphate receptor, Cell 50:181 (1987).
R. Pohlmann, G. Nagel, B. Schmidt, M. Stein, G. Lorkowski, C. Krentler, J. Cully, H. E. Meyer, K-H Grzeschik, G. Mersmann, A. Hasilik, and K. von Figura, Cloning of a cDNA encoding the human cation-dependent mannose 6-phosphate-specific receptor, Proc. Natl. Acad. Sci. USA. 84:5575 (1987).
J. S. Flier, P. Usher, and A. C. Moses, Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts, Proc. Natl. Acad. Sci. USA 83:664 (1986).
J. J. Van Wyk, D. C. Graves, S. J. Casella, and S. Jacobs, Evidence from monoclonal antibody studies that insulin stimulates deoxyribonucleic acid synthesis through the type I somatomedin receptor, J. Clin. Endocrinol. Metab. 61:639 (1985).
C. A. Conover, P. Misra, R. L. Hintz, and R. G. Rosenfeld, Effect of an anti-insulinlike growth factor I receptor antibody on insulin-like growth factor II stimulation of DNA synthesis in human fibroblasts, Biochem. Biophys Res. Commun. 139:501 (1986).
R. W. Furlanetto, J. N. DiCarlo, and C. Wisehart, The type II insulin-like growth factor receptor does not mediate deoxyribonucleic acid synthesis in human fibroblasts, J. Clin. Endocrinol. Metab. 64:1142 (1987).
C. Mottola and M. P. Czech, The type II insulin-like growth factor receptor does not mediate increased DNA synthesis in H-35 hepatoma cells, J. Biol. Chem. 259:12705 (1984).
W. Kiess, J. F. Haskell, L. Lee, L. A. Greenstein, B. E. Miller, A. L. Aarons, M. M. Rechler, and S. P. Nissley, An antibody that blocks insulin-like growth factor (IGF) binding to the type II IGF receptor is neither an agonist nor an inhibitor of IGF-stimulated biologic responses in L6 myoblasts, J. Biol. Chem. 262:12745 (1987).
M. R. Hammerman and J. R. Gavin, Binding of insulin-like growth factor II and multiplication-stimulating activity-stimulated phosphorylation in basolateral membranes from dog kidney, J. Biol. Chem. 259:13511 (1984).
J. Mellas, J. R. Gavin, and M. R. Hammerman, Multiplication-stimulating activity-induced alkalinization of canine renal proximal tubular cells, J. Biol. Chem. 261:14437 (1986).
S. A. Rogers, and M. R. Hammerman, Insulih-like growth factor II stimulates production of inositol trisphosphate in proximal tubular basolateral membranes from dog kidney, Proc. Natl. Acad. Sci. USA 85:4037 (1988).
E. J. Verspohl, R. A. Roth, R. Vigneri, and I. D. Goldfine, Dual regulation of glycogen metabolism by insulin and insulin-like growth factors in human hepatoma cells (HEP-G2), J. Clin. Invest. 74:1436 (1984).
J. Hari, S. B. Pierce, D. O. Morgan, V. Sara, M. C. Smith, and R. A. Roth, The receptor for insulin-like growth factor II mediates an insulin-like response, EMBO J. 6:3367 (1987).
Nishimoto, Y. Hata, E. Ogata, and I. Kojima, Insulin-like growth factor II stimulates calcium influx in competent BALB/c 3T3 primed with epidermal growth factor, J. Biol. Chem. 262:12120 (1987).
I. Kojima, I. Nishimoto, T. Iiri, E. Ogata, and R. Rosenfeld, Evidence that type II insulin-like growth factor receptor is coupled to calcium gating system, Biochem. Biophys. Res. Commun. 154:9 (1988).
I. Nishimoto, E. Ogata, and I. Kojima, Pertussis toxin inhibits the action of insulin-like growth factor-I, Biochem Bipophvs. Res. Commun. 148:403 (1987).
M. Tally, C. H. Li, and K. Hall, IGF-2 stimulated growth mediated by the somatomedin type 2 receptor, Biochem. Biophvs. Res. Commun. 148:811 (1987).
M. M. Blanchard, B. Barenton, A. Sullivan, B. Foster, H. H. Guyda, and B. I. Posner, Characterization of the insulin-like growth factor (IGF) receptor in K562 erythroleukemia cells; evidence for a biological function for the type II IGF receptor, Molec. Cell. Endocrinol. 56:235 (1988).
N. Hizuka, I. Sukegawa, K. Takano, K. Asakawa, R. Horikawa, T. Tsushima, and K. Shizume, Characterization of insulin-like growth factor I receptors on human erythroleukemia cell line (K-562 cells), Endocrinol. Japon. 34:81 (1987).
R. L. Hintz, A. V. Thorsson, G. Enberg, and K. Hall, IGF-II binding on human lymphoid cells: demonstration of a common high affinity receptor for insulin like peptides, Biochem. Biophvs. Res. Commun. 118:774 (1984).
P. Misra, R. L. Hintz, and R. G. Rosenfeld, Structural and immunological characterization of insulin-like growth factor II binding to IM-9 cells, J. Clin. Endocrinol. Metab, 63:1400 (1986).
S. J. Casella, V. K. Han, A. J. D’Ercole, M. E. Svoboda, and J. J. Van Wyk, Insulinlike growth factor II binding to the type I somatomedin receptor, J. Biol. Chem. 261:9268 (1986).
C. Polychronakos, H. J. Guyda, and B. I. Posner, Mannose-6-phosphate increases the affinity of its cation-independent receptor for insulin-like growth factor II by displacing inhibitory endogenous ligands, Biochem. Biophys. Res. Commun. 157:632 (1988).
W. Kiess, C. L. Thomas, L. A. Greenstein, L. Lee, M. M. Sklar, M. M. Rechler, G. G. Sahagian, and S. P. Nissley, Insulin-like growth factor-II (IGF-II) inhibits both the cellular uptake of β-galactosidase and the binding of β-galactosidase to purified IGF-II/mannose 6-phosphate receptor, J. Biol. Chem. 264:4710 (1989).
A. C. Moses, S. P. Nissley, P. A. Short, M. M. Rechler, R. M. White, A. B. Knight, and O. Z. Higa, Increased levels of multiplication-stimulating activity, an insulin-like growth factor, in fetal rat serum, Proc. Natl. Acad. Sci. USA 77:3649 (1980).
A. L. Brown, D. E. Graham, S. P. Nissley, D. J. Hill, A. J. Strain, and M. M. Rechler, Developmental regulation of insulin-like growth factor II mRNA in different rat tissues, J. Biol Chem. 261:13144 (1986).
M. M. Sklar, W. Kiess, C. L. Thomas, L. Lee, and S. P. Nissley, Developmental expression of tissue insulin-like growth factor-II (IGF-II)/mannose-6-phosphate (M6P) receptor in the rat. Measurement by quantitative immunoblotting, J. Biol. Chem. in press (1989).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Nissley, P., Kiess, W., Sklar, M. (1989). The Insulin-Like Growth Factor-II/Mannose 6-Phosphate Receptor. In: LeRoith, D., Raizada, M.K. (eds) Molecular and Cellular Biology of Insulin-like Growth Factors and Their Receptors. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5685-1_30
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5685-1_30
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5687-5
Online ISBN: 978-1-4684-5685-1
eBook Packages: Springer Book Archive